CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the Clinic – Targeted Oncology
CAR T-Cell Therapies for Hematologic Malignancies Moving Toward the ClinicTargeted OncologyUpdated results from ZUMA-3, a phase 1/2 study of KTE-C19 chimeric antigen receptor (CAR) T cell therapy, in adults with high-burden relapsed/refrac- tory acute … Continue reading
